Member Info for andsoforth

Revenue exceeds estimates.
"cargo forwarding business delivered a record performance"
" Underlying operating cash flow, ahead of expectations"

Pretty decent results for a very difficult period.

Results due in the morning, I believe. Good luck all!

Revenue exceeded estimates, and managed an operating profit. Well played!

There is now a clearly stated dividend policy here, over a protracted period. In these uncertain times this may now be viewed by some as a bond proxy, and indeed we may see a slow but steady appreciation. Happy to hold.

Wee profit, wee dividend. Good signs of a recovery.

"Total FUMA reached £54.7 billion at 31 December 2020, up 8.5% from £50.4 billion at 31 December 2019
- £44.9 billion in the Investment Management business, up 4.4% (2019: £43.0 billion)
- £9.8 billion in the funds business, up 32.4% (2019: £7.4 billion)
- Total net inflows across the group were £2.1 billion (2019: £0.6 billion), representing a growth rate of 4.2% (2019: 1.3%)
- Gross organic inflows in Investment Management were consistent at £3.3 billion in 2020 compared to £3.3 billion in the prior year
- Acquired inflows of £0.6 billion in Investment Management largely reflect the transfer of assets from Barclays Wealth (£0.4 billion)
- Investment Management outflows for the year totalled £3.3 billion (2019: £3.9 billion)
- Net inflows in our funds business were £1.5 billion (2019: £0.9 billion)"

Dividend raised 2%.
Pretty decent results.

Forecasts beaten Good job!

Beat forecasts due to selling off parts of the business. Good job!

Apologies. My error. To be exact the company "provides [an] integrated mobility solutions platform". ; )

Good wee company that has managed to diversify recently. Balance sheet seems fine, Maybe wait until results tomorrow? Consensus estimates are:
EPS = -0.11p, Revenue = £259m.

Have a look at WG.? Very strong cashflow.

Forecast EPS = 27.26, Revenue = £23,699m,
Good luck all.

The PER is 8.4, the Price to Book is 0.8, and the yield should be around 3%; so the figures don't add up too badly here. For what they re worth, Barclays issued a note in August with a target price of 317, and Peel Hunt suggested in March that there was a 300 target, having reduced from 400. The primary business is van leasing, in the UK and Spain. Amongst the major Customers are RMG. Revenues are also made by van sales, and the company has also taken in an accident management firm and a chain of crash repair workshops in the last year or so, the latter out of bankruptcy and the former in the wake of poor trading. These businesses should be a good fit, and according to the last update in December things are going well. Amongst the assets acquired was an allegedly decent management team. The Chairman has in fact proved so effective in one former employment, the workers slashed the tyres on her BMW (google it!!)
The company has traded well since November, despite Covid restrictions. The boom in home shopping has pushed up the prices of on-line retailers and the owners of their warehousing, but so far little has been said of the middle men, that is the fleet of delivery drivers and vehicles. REDD are the great enablers in this field. On the dark side there is a lot of debt here, in fact 50% or so of the market cap, but that should remain manageable as interest rates remain low.
Overall I think we should see 300 here, and hopefully more. Synergies in management, the extending of van lease life to three years, and newer revenue streams should all help.

Possible profit taking. Many holders here bought sub-10, and these can be seen as virus-enhanced results. Paul Scott has labelled this as a decent company, but overpriced. He may be right at a PER of 20. Results are pretty much as expected. May re-rate, but it may be 2022.

A lot to agree with here:
"Added to my holding in GSK. Their YE 2020 results were as poor as expected and really demonstrated the lack of leadership at the company at present. Management seems focussed on the fact that it will split the businesses in 2022, and being polite. until then we seem to have a holding operation. Aligned with possibly the most boring Investor/Analysts presentations of any large company. Whilst killing time till the split the company continues to be profitable, cash generative and a big dividend payer (though the company has signalled that with the spilt the dividend levels will be reconsidered). I am nervously holding until we get the 2 company structures and we can see whether they have management that can take the businesses forward. I am not convinced that we are not in the period where they intention is to sandbag so as to allow the newco and its management to look good. My average in is now 1338.4p. I think it only fair to say that whilst I have added a couple of people who may know more about this field than I do see the vaccine business of GSK as being very poor quality and therefore GSK as heading for a much smaller overall business. Killick in their weekly update were very negative on GSK. Also Bocconni described the dividend changes as desperate as they see management having to spend to build up a worthwhile pharmaceutical portfolio. It is quite possible that GSK’s main positive is almost everyone thinks it stinks. It therefore has become the purview of only bottom feeding value investors and I note one or two of these are declaring GSK holdings."

They have it as a "super stock"! The PER is 12, and the yield is possibly 4.5%. Price has been suppressed by Mawer selling, though AV. now hold 6%. Fourth quarter results last month saw FuM&A up 8%, and rises across the board. Results are available on Thursday. Seems a decent, solid firm.

Long term holder here. There seems little interest from private investors, although Paul Scott said recently on Stockopedia that the current price represented value. On a PER of 9.6 and the distinct possibility of a reinstated dividend when food service opens again, I think he is right. Hold long enough and it will hit a quid, but the low margins and company debt mean this will never be a top rated investment. I would settle for 90.

Hunting (HTG) also. PFC, HTG and WG. are all far from expensive.

Recent broker targets are 1150 and below. This probably has further to fall. In the longer term the company should prosper and give handsome returns, but before that you will be able to buy in at a lower price.

Interims on Tuesday. Good luck!

Interims on Tuesday. Good luck!